Hemostasis system and uterine scar formation in women undergoing conservative myomectomy


Keywords: uterine scar, conservative myomectomy, hemostasis, pathomorphosis.

Abstract

Annotation. The aim of the study was to assess the characteristics of hemostasis and the formation of a scar on the uterus in women who underwent conservative myomectomy. Medical records of 426 women with a scar on the uterus were analyzed. The results of pathomorphological examination of biopsy materials obtained in the area of the “old” scar during myomectomy with recurrence of fibroids with a gestational age of 33 to 40 weeks. The micromorphological structure of postoperative scars and pericycatric region of the myometrium was determined and immunohistochemical examination was performed on serial paraffin sections of biopsy material using primary and secondary monoclonal antibodies of Dako kits (USA). To quantify the immunohistochemical results in the sections, the number of cells in which the immunoperoxidase label (positive staining) was detected in 10 fields of view randomly selected (>200 cells) was counted. FW expression was determined using a semi-quantitative method with H-score calculation. Statistical processing of the obtained results was performed by non-parametric methods using the software TIBCO Statistica 13.5 (USA). It was shown that 40.1% of uterine scars are due to conservative myomectomy. In the postoperative period, patients who underwent conservative myomectomy have a tendency to hypercoagulation, while the frequency of thromboembolic complications after conservative myomectomy does not exceed 3%. High FW expression indicates the presence of endothelial dysfunction and should be taken into account when assessing the risk of thromboembolic complications in patients after conservative myomectomy.

References

[1] Bancroft, J. D., & Gamble, M. (2008). Theory and practice of histological techniques. (6-ed.). Churchill Livingstone, Elsevier, China. ISBN:9780443102790

[2] Barashyan, L. G., Lalayan, R. S., Kazmenkova, E. M., Bondarenko, N. Yu., Cherednichenko, A.A., & Kibishev, Z. B. (2019). Морфологические исследования рубца на матке при кесаревом сечении [Morphological examination of the uterine scar during cesarean section]. Уральский научный вестник - Ural Scientific Bulletin, 5(3), 12-15.

[3] Chen, Y., Han, P., Wang, Y. J., & Li, Y. X. (2017). Risk factors for incomplete healing of the uterine incision after cesarean section. Arch Gynecol Obstet., 296(2), 355-361. doi: 10.1007/s00404-017-4417-6

[4] Closon, F., & Tulandi, T. (2016). Uterine myomata: Organ-preserving surgery. Best Pract Res Clin Obstet Gynaecol., 35, 30-6. doi: 10.1016/j.bpobgyn.2015.09.005

[5] Huang, C., & Ding, D. C. (2019). Outcomes of adhesion barriers in gynecologic surgeries: A retrospective study at a medical center. Medicine (Baltimore), 98(50), e18391. doi: 10.1097/MD.0000000000018391

[6] James, A. H. (2018). Foreword: The Prevention and Management of Thrombosis in Obstetrics and Gynecology. Clin Obstet Gynecol., 61(2), 203-205. doi: 10.1097/GRF.0000000000000373

[7] Khalafyan, A. L., Borovikov, V. P., & Kalaydina, G. V. (2016). Теория вероятностей, математическая статистика и анализ данных: Основы теории и практика на компьютере. STATISTICA. EXCEL. Более 150 примеров решения задач. Учебное пособие [Probability theory, mathematical statistics and data analysis: Fundamentals of theory and practice on a computer. STATISTICA. EXCEL. More than 150 examples of problem solving. Tutorial]. Ленанд – Lenand. ISBN: 978-5-9710-3040-9

[8] Kumar, G. L., & Rudbeck, L. (2009). Immunohistochemical Staining Methods Education Guide. (5th ed.). Dako.

[9] Ministry of Health of Ukraine (2007). Наказ МОЗ України №329 від 15.06.2007 “Про затвердження клінічних протоколів надання медичної допомоги з профілактики тромботичних ускладнень в хірургії, ортопедії і травматології, акушерстві та гінекології” [Order of the Ministry of Health of Ukraine №329 from 15.06.2007 “On approval of clinical protocols for medical care for the prevention of thrombotic complications in surgery, orthopedics and traumatology, obstetrics and gynecology”].

[10] Pomorski, M., Fuchs, T., Rosner-Tenerowicz, A., & Zimmer, M. (2017). Morphology of the cesarean section scar in the non-pregnant uterus after one elective cesarean section. Ginekol Pol., 88(4), 174-179. doi: 10.5603/GP.a2017.0034

[11] Shlapak, I. M. (2013). Клинико-функциональные и иммуногистохимические критерии нeсостоятельности рубца на матке после операции кесарева сечения [Clinical, functional and immunohistochemical criteria for uterine scar failure after cesarean section]. Здоровье женщины – Woman's health, 5(81), 74-76.

[12] Vakalyuk, L. M. (2014). Рубець на матці після кесарева розтину за клінічним та морфофункціональним аналізом [Scar on the uterus after cesarean section by clinical and morphofunctional analysis]. Здоровье женщины – Woman's health , 3, 91-93.

[13] van der Voet, L. F., Jordans, I. P. M., Brölmann, H. A. M., Veersema, S., & Huirne, J. A. F. (2018). Changes in the Uterine Scar during the First Year after a Caesarean Section: A Prospective Longitudinal Study. Gynecol Obstet Invest., 83(2), 164-170. doi: 10.1159/000478046

[14] Vervoort, A. J., Uittenbogaard, L. B., Hehenkamp, W. J., Brölmann, H. A., Mol, B. W., & Huirne, J. A. (2015). Why do niches develop in Caesarean uterine scars? Hypotheses on the aetiology of niche development. Hum Reprod., 30(12), 2695-2702. doi: 10.1093/humrep/dev240

[15] Zhelezov, D. (2019). Periconceptional remodeling of myometrium after surgical interventions on the uterus: ultrasonographic aspects. Georgian Med News, 297, 31-34.

[16] Zhelezov, D., Savenko, T., & Zhovtenko, O. (2019). Pathomorphosis of pericicatricial myometrium: a new view concerning the problem of uterine scar. Deutscher Wissenschaftsherold, 4, 27-30. DOI:10.19221/201946
Published
2021-06-24
How to Cite
Zhelezov, D. M. (2021). Hemostasis system and uterine scar formation in women undergoing conservative myomectomy. Reports of Vinnytsia National Medical University, 25(2), 201-204. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2021-25(2)-03